FI49298C - Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi. - Google Patents
Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi.Info
- Publication number
- FI49298C FI49298C FI691646A FI164669A FI49298C FI 49298 C FI49298 C FI 49298C FI 691646 A FI691646 A FI 691646A FI 164669 A FI164669 A FI 164669A FI 49298 C FI49298 C FI 49298C
- Authority
- FI
- Finland
- Prior art keywords
- aryloxymethylpiperidine
- antidepressants
- preparation
- derivatives useful
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Farming Of Fish And Shellfish (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27502/68A GB1203149A (en) | 1968-06-10 | 1968-06-10 | Piperidine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI49298B FI49298B (fi) | 1975-01-31 |
| FI49298C true FI49298C (fi) | 1975-05-12 |
Family
ID=10260615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI691646A FI49298C (fi) | 1968-06-10 | 1969-06-02 | Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3634437A (fi) |
| JP (1) | JPS4934990B1 (fi) |
| AT (1) | AT289115B (fi) |
| BE (1) | BE734296A (fi) |
| BR (1) | BR6909577D0 (fi) |
| CH (1) | CH513856A (fi) |
| CS (1) | CS153519B2 (fi) |
| DE (1) | DE1929260A1 (fi) |
| DK (1) | DK120996B (fi) |
| ES (1) | ES368169A1 (fi) |
| FI (1) | FI49298C (fi) |
| FR (1) | FR2010615A1 (fi) |
| GB (1) | GB1203149A (fi) |
| IE (1) | IE33092B1 (fi) |
| IL (1) | IL32278A (fi) |
| NL (1) | NL6908842A (fi) |
| NO (1) | NO125928B (fi) |
| PL (1) | PL79996B1 (fi) |
| SE (1) | SE356978B (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556664A (en) * | 1984-03-13 | 1985-12-03 | Gunnar A. K. Aberg | Method and composition for the treatment of cardiac arrhythmias |
| IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
| US4822778A (en) * | 1988-01-19 | 1989-04-18 | Gunnar Aberg | Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds |
| FR2667317B1 (fr) * | 1990-10-02 | 1992-12-04 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| GB9226111D0 (en) * | 1992-12-15 | 1993-02-10 | Smithkline Beecham Plc | Madicaments |
| CA2232147A1 (en) * | 1997-04-03 | 1998-10-03 | F. Hoffmann-La Roche Ag | Phenoxymethyl piperidine derivatives |
| US6110937A (en) * | 1997-04-03 | 2000-08-29 | Syntex Usa, Inc. | Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain |
| US6518284B2 (en) * | 1998-11-18 | 2003-02-11 | Faes, Fabrica Espanola De Productos Quimicos Y Farmaceuticos S.A. | 4-substituted piperidines |
| ES2157148B1 (es) * | 1998-11-18 | 2002-03-01 | Faes Fabrica Espanola De Produ | Nuevas piperidinas 4-sustituidas. |
| EP1854785A1 (en) * | 2006-05-12 | 2007-11-14 | Faes Farma, S.A. | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| WO2008023258A1 (en) * | 2006-08-23 | 2008-02-28 | Pfizer Products Inc. | Piperidine derivatives |
| TWI438190B (zh) * | 2008-07-24 | 2014-05-21 | Theravance Inc | ３－（苯氧基苯基甲基）吡咯啶化合物 |
| US20100267743A1 (en) * | 2009-04-15 | 2010-10-21 | Stangeland Eric L | 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds |
| CA2767372A1 (en) * | 2009-07-13 | 2011-01-20 | Theravance, Inc. | 3-phenoxymethylpyrrolidine compounds |
| ES2495366T3 (es) | 2009-07-21 | 2014-09-17 | Theravance, Inc. | Compuestos de 3-fenoximetilpirrolidina |
| KR101114544B1 (ko) | 2009-10-15 | 2012-03-07 | 한국원자력의학원 | Ｎｒｆ2 활성 억제제 및 그의 용도 |
| CA2811641A1 (en) | 2010-10-11 | 2012-04-19 | Theravance, Inc. | Serotonin reuptake inhibitors |
| US8501964B2 (en) | 2010-12-03 | 2013-08-06 | Theravance, Inc. | Serotonin reuptake inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3381013A (en) * | 1964-01-15 | 1968-04-30 | Bristol Myers Co | Heterocyclicamino ethers of benzylphenols |
-
1968
- 1968-06-10 GB GB27502/68A patent/GB1203149A/en not_active Expired
-
1969
- 1969-05-15 IE IE671/69A patent/IE33092B1/xx unknown
- 1969-05-19 US US825934A patent/US3634437A/en not_active Expired - Lifetime
- 1969-05-19 PL PL1969133681A patent/PL79996B1/pl unknown
- 1969-05-22 IL IL32278A patent/IL32278A/en unknown
- 1969-05-28 DK DK289269AA patent/DK120996B/da unknown
- 1969-06-02 FI FI691646A patent/FI49298C/fi active
- 1969-06-06 SE SE08089/69A patent/SE356978B/xx unknown
- 1969-06-09 CS CS406769A patent/CS153519B2/cs unknown
- 1969-06-09 BR BR209577/69A patent/BR6909577D0/pt unknown
- 1969-06-09 ES ES368169A patent/ES368169A1/es not_active Expired
- 1969-06-09 NO NO2370/69A patent/NO125928B/no unknown
- 1969-06-09 BE BE734296D patent/BE734296A/xx unknown
- 1969-06-10 JP JP44045698A patent/JPS4934990B1/ja active Pending
- 1969-06-10 CH CH878169A patent/CH513856A/de not_active IP Right Cessation
- 1969-06-10 DE DE19691929260 patent/DE1929260A1/de active Pending
- 1969-06-10 FR FR6919217A patent/FR2010615A1/fr not_active Withdrawn
- 1969-06-10 NL NL6908842A patent/NL6908842A/xx unknown
- 1969-06-10 AT AT549669A patent/AT289115B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE33092B1 (en) | 1974-03-20 |
| ES368169A1 (es) | 1971-05-01 |
| IL32278A0 (en) | 1969-07-30 |
| BE734296A (fi) | 1969-12-09 |
| US3634437A (en) | 1972-01-11 |
| CS153519B2 (fi) | 1974-02-25 |
| DE1929260A1 (de) | 1970-08-27 |
| IE33092L (en) | 1969-12-10 |
| IL32278A (en) | 1972-10-29 |
| NO125928B (fi) | 1972-11-27 |
| JPS4934990B1 (fi) | 1974-09-19 |
| DK120996B (da) | 1971-08-16 |
| FR2010615A1 (fi) | 1970-02-20 |
| CH513856A (de) | 1971-10-15 |
| NL6908842A (fi) | 1969-12-12 |
| PL79996B1 (fi) | 1975-08-30 |
| SE356978B (fi) | 1973-06-12 |
| FI49298B (fi) | 1975-01-31 |
| BR6909577D0 (pt) | 1973-05-24 |
| AT289115B (de) | 1971-04-13 |
| GB1203149A (en) | 1970-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI49298C (fi) | Menetelmä masennuslääkkeenä käytettävien 3-aryylioksimetyylipiperidiin ijohdannaisten valmistamiseksi. | |
| DK122964B (da) | Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater. | |
| FI49716C (fi) | Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi. | |
| FI47572C (fi) | Menetelmä 19-norandrost-4-eeni-3,17-dionien valmistamiseksi. | |
| FI50334C (fi) | Menetelmä 1-hydroksi-2pyridonien valmistamiseksi. | |
| FI47575C (fi) | Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi. | |
| FI52216C (fi) | Menetelmä gamma-piperidinobutyrofenonijohdannaisten valmistamiseksi. | |
| DK120292B (da) | Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater. | |
| FI47577C (fi) | Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä. | |
| FI49161C (fi) | Menetelmä kardenolidi-3-(2´,3´-didesoksi-2´,3´-oksido-glykosidien) val mistamiseksi. | |
| FI46727C (fi) | Menetelmä pyridatsolijohdannaisten valmistamiseksi. | |
| FI47763C (fi) | Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi. | |
| FI47576C (fi) | Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi. | |
| FI49029C (fi) | Menetelmä 15alfa,16alfa-metyleeniandrosteenijohdannaisten valmistamise ksi | |
| FI52088C (fi) | Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi. | |
| FI49160C (fi) | Menetelmä 6alfa-fluori-16alfa,18-dimetyyli-1,4-pregnadien-3,20-dionijo hdannaisten valmistamiseksi. | |
| FI48835C (fi) | Menetelmä matolääkkeenä käytettävien beta,beta,beta-trikloorietylideen ijohdannaisten valmistamiseksi. | |
| FI47349C (fi) | Menetelmä 17alfa-propadienyyli-17beta-hydroksi-steroidien valmistamise ksi. | |
| FI44621C (fi) | Menetelmä hypertensiivisten 3,4-dihydroksifenyylipropaani-johdannaiste n valmistamiseksi. | |
| FI51180C (fi) | Analogiamenetelmä anti-Trichomonas-aktiviteetin omaavien 2-nitro-imida tsoli-johdannaisten valmistamiseksi. | |
| FI51814C (fi) | Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi. | |
| FI46724C (fi) | Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi. | |
| FI46384C (fi) | Menetelmä lääkeaineina vaikuttavien adenosiinijohdannaisten valmistami seksi. | |
| FI48836C (fi) | Menetelmä imidatsolinyylifenyylikarbonyylijohdannaisten valmistamiseks i. | |
| FI49506C (fi) | Menetelmä imidatsolinyylifenyylikarbonyylijohdannaisten valmistamiseks i. |